Bio-Works Technologies AB Share Price
Equities
BIOWKS
SE0007387089
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.94 SEK | -2.00% | -22.63% | -58.59% |
Sales 2021 | 56.36M 5.15M 430M | Sales 2022 | 41.32M 3.78M 315M | Capitalization | 736M 67.32M 5.61B |
---|---|---|---|---|---|
Net income 2021 | -12M -1.1M -91.46M | Net income 2022 | -45M -4.11M -343M | EV / Sales 2021 | 15.2 x |
Net cash position 2021 | 103M 9.39M 783M | Net cash position 2022 | 65.88M 6.02M 502M | EV / Sales 2022 | 16.2 x |
P/E ratio 2021 |
-66.3
x | P/E ratio 2022 |
-16.4
x | Employees | 36 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 56.22% |
1 day | -2.00% | ||
1 week | -22.63% | ||
Current month | -28.64% | ||
1 month | -28.29% | ||
3 months | -48.06% | ||
6 months | -59.28% | ||
Current year | -58.59% |
Managers | Title | Age | Since |
---|---|---|---|
Jonathan Royce
CEO | Chief Executive Officer | 47 | 26/20/26 |
Founder | - | 01/06/01 | |
Arne Hauge
DFI | Director of Finance/CFO | - | 01/23/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Corporate Officer/Principal | 71 | 24/13/24 | |
Johan Sedihn
BRD | Director/Board Member | 59 | 15/20/15 |
Peter Nählstedt
BRD | Director/Board Member | 50 | 15/20/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 2.94 | -2.00% | 46,634 |
25/24/25 | 3 | +8.70% | 40,711 |
24/24/24 | 2.76 | -2.13% | 34,771 |
23/24/23 | 2.82 | -2.76% | 45,698 |
22/24/22 | 2.9 | -23.68% | 241,749 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 08:47 pm IST
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-58.59% | 10.45M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- BIOWKS Stock